Media Mention

Sarah Burg featured in Law360 Article, “How Patent Attys Can Limit 'Skinny Label' Risks In Ads”

August 08, 2025

Foley Hoag partner Sarah Burg was quoted in the Law360 article, “How Patent Attys Can Limit 'Skinny Label' Risks In Ads” published on August 8, 2025. The article discusses the heightened importance of specificity in generic drug marketing following recent Federal Circuit decisions. Sarah emphasized that each case is highly fact-specific and underscored the need for legal counsel to be closely involved in reviewing marketing materials to ensure compliance and mitigate the risk of induced patent infringement. The full article can be viewed here.